Shire Wrings Life Out Of Adderall XR Despite Actavis Generic Launch
This article was originally published in The Pink Sheet Daily
Executive Summary
Branded Adderall XR will remain competitive, Shire CEO Angus Russell predicts during the company’s second quarter sales and earnings call, despite the launch of the first generic.